UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
ANI Pharmaceuticals
ANIP
$1.72B
| $2.04M | ﹤0.01% |
31,974
+14,512
| +83% | +$942K |
|
3752
Cathay General Bancorp
CATY
$4.23B
| $2.03M | ﹤0.01% |
53,916
-29,652
| -35% | -$1.08M |
|
3753
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.17B
| $2.03M | ﹤0.01% |
+40,774
| New | +$2.03M |
|
|
DEC
3754
Diversified Energy Company
DEC
$1.01B
| $2.03M | ﹤0.01% |
150,325
-536,774
| -78% | -$7.47M |
|
3755
Navient
NAVI
$796M
| $2.02M | ﹤0.01% |
138,932
-24,587
| -15% | -$380K |
|
|
RMI
3756
RiverNorth Opportunistic Municipal Income Fund
RMI
$101M
| $2.02M | ﹤0.01% |
127,143
+6,726
| +6% | +$106K |
|
3757
Westamerica Bancorp
WABC
$1.35B
| $2.02M | ﹤0.01% |
41,629
-248
| -0.6% | -$11.9K |
|
|
FCT
3758
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $2.01M | ﹤0.01% |
199,340
-4,646
| -2% | -$47.8K |
|
3759
Viking Holdings
VIK
$46.3B
| $2M | ﹤0.01% |
+59,034
| New | +$1.78M |
|
|
MRSH
3760
PUT
Marsh
MRSH
$91B
| $2M | ﹤0.01% |
9,500
+5,000
| +111% | +$1.03M |
|
3761
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
| $2M | ﹤0.01% |
98,821
+83
| +0.1% | +$1.68K |
|
3762
Cohu
COHU
$2.34B
| $1.99M | ﹤0.01% |
60,263
+21,089
| +54% | +$655K |
|
3763
Portillo's
PTLO
$325M
| $1.99M | ﹤0.01% |
205,188
+142,828
| +229% | +$1.59M |
|
3764
Radware
RDWR
$1.2B
| $1.99M | ﹤0.01% |
109,310
+74,740
| +216% | +$1.36M |
|
3765
CALL
CRISPR Therapeutics
CRSP
$5.17B
| $1.99M | ﹤0.01% |
36,899
-2,185
| -6% | -$126K |
|
3766
PUT
Pan American Silver
PAAS
$21.8B
| $1.99M | ﹤0.01% |
+100,000
| New | +$1.97M |
|
3767
CALL
Vipshop
VIPS
$7.4B
| $1.99M | ﹤0.01% |
152,618
-178,482
| -54% | -$2.84M |
|
3768
Apogee Therapeutics
APGE
$10.2B
| $1.99M | ﹤0.01% |
50,490
-25,541
| -34% | -$1.24M |
|
3769
CALL
US Bancorp
USB
$100B
| $1.99M | ﹤0.01% |
50,000
-22,500
| -31% | -$918K |
|
3770
Signet Jewelers
SIG
$3.67B
| $1.98M | ﹤0.01% |
22,154
-19,995
| -47% | -$1.98M |
|
3771
CALL
CarMax
KMX
$8.34B
| $1.98M | ﹤0.01% |
27,000
| – | – |
|
3772
Walker & Dunlop
WD
$1.49B
| $1.98M | ﹤0.01% |
20,145
-12,293
| -38% | -$1.17M |
|
3773
PUT
Nice
NICE
$6.01B
| $1.98M | ﹤0.01% |
+11,500
| New | +$2.37M |
|
3774
PUT
iShares MSCI India ETF
INDA
$6.6B
| $1.97M | ﹤0.01% |
35,400
-220,700
| -86% | -$11.7M |
|
|
SAFE
3775
Safehold
SAFE
$1.09B
| $1.97M | ﹤0.01% |
102,290
-1,301,888
| -93% | -$25M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.